Eden Biodesign LLC

General

Total Cases14
Active Cases2
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
L5
E
PTAB
L5
A
CAFC
L5
E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
12/18/24
Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding status. (Tigan, Jeremy) Modified on 12/18/2024 (nms). (Entered: 12/18/2024)
12/17/24
CORRECTING ENTRY: The stipulation filed at D.I. 495 on 12/17/2024, has been removed per the filer's request as it contained errors. (nms) (Entered: 12/17/2024)
12/11/24
STIPULATION and Proposed Order - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 12/11/2024 (nms). (Entered: 12/11/2024)
12/11/24
SO ORDERED, re [494] STIPULATION and Proposed Order (*Reset Deadlines: Status Report due by 12/18/2024). Signed by Judge Richard G. Andrews on 12/11/2024. (nms) (Entered: 12/11/2024)
12/02/24
SO ORDERED Granting [490] Stipulation and Proposed Order (*Sun Pharmaceutical Industries Limited terminated). Signed by Judge Richard G. Andrews on 12/2/2024. (nms) (Entered: 12/02/2024)
11/27/24
ORAL ORDER: A joint status letter is due by December 11, 2024. Ordered by Judge Richard G. Andrews on 11/27/2024. (nms) (Entered: 11/27/2024)
11/27/24
MANDATE of USCA as to [488] Notice of Appeal (Federal Circuit), filed by Allergan USA, Inc., Eden Biodesign, LLC, Allergan Holdings Unlimited Company. USCA Decision: Reversed. (Attachments: # [1] Opinion, # [2] Judgment)(nms) (Entered: 11/27/2024)
11/27/24
STIPULATION of Dismissal between Plaintiffs and Sun Pharmaceutical Industries Limited, by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/27/2024 (nms). (Entered: 11/27/2024)
11/26/24
SO ORDERED Granting [80] Stipulation and Proposed Order (*Party Sun Pharmaceutical Industries Limited terminated). Signed by Judge Richard G. Andrews on 11/26/2024. (nms) (Entered: 11/26/2024)
11/26/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,097,187 B2. (Attachments: # [1] Order)(nms) (Entered: 11/26/2024)